Biosimilars vs. Ustekinumab: What’s the Future of ..

새 기사를 만들었습니다

1 안에 - 번역하다

Biosimilars vs. Ustekinumab: What’s the Future of Biologic Therapies? | # #ustekinumab #biologictherapies #autoimmunedisease #psoriasistreatment #ibdtreatment #crohnsdisease #psoriaticarthritis

Biosimilars vs. Ustekinumab: What’s the Future of Biologic Therapies?

Biosimilars vs. Ustekinumab: What’s the Future of Biologic Therapies?

Primarily used for psoriasis, psoriatic arthritis, and Crohn’s disease, Ustekinumab’s expanding applications are fueling significant growth in its market. The increasing prevalence of chronic inflammatory diseases and the demand for biologic therapies are key drivers shaping the Usteki

처럼

논평

공유하다